Trial · NCT04365985
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Progression of Oxygenation Needs | up to 1 month | Count of participants initially presenting with mild/moderate disease who progress to requiring advanced oxygenation (high flow nasal canula, non-rebreather, continuous positive airway pressure (CPAP), bilevel positive airway pressure (BIPAP), or intubation) |
| Secondary | Renal Failure | up to 1 month | Count of participants who develop or experience worsened renal failure as defined by RIFLE criteria, a 5-point scale where the categories are labeled: Risk-Injury-Failure-Loss-End stage renal disease, with Risk being the least severe and End stage renal disease being the most severe. The criteria for determination of stage are factors of serum creatinine and urine output. Numbers of participants worsening one or more RIFLE stages will be reported. |
| Secondary | Liver Failure | up to 1 month | Count of participants who develop or experience worsened liver failure as defined by serum transaminases five times normal limits |
| Secondary | Cytokine Storm | up to 1 month | Count of participants who develop cytokine storm as measured by elevated markers of inflammation (elevated D-dimer, hypofibrinogenemia, hyperferritinemia), evidence of acute respiratory distress syndrome (ARDS) measured by imaging findings and mechanical ventilator requirements, and/or continuous fever (≥ 38.1 ° Celsius unremitting) |
| Secondary | COVID Mortality | up to 1 month post hospital discharge | Count of participants who die from COVID-19 |
| Secondary | Length of Hospital Stay | up to 1 month | Length of hospital stay in days |
| Secondary | Intensive Care Unit (ICU) Admission | up to 1 month | Count of patients admitted to the ICU at any time during index hospitalization |
| Secondary | Intensive Care Unit (ICU) Duration | up to 1 month | Length of ICU stay in days |
| Secondary | Intubation | up to 1 month | Count of participants requiring intubation |
| Secondary | Intubation Duration | up to 1 month | Length of intubation, measured in days |
| Secondary | Time Until Recovery | up to 1 month | Time measured in days from hospital admission to determination patient is stable for discharge |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04365985/registered